Medical Health & Life Science Research News

Europe migraine drug market is expected to reach USD 1.33 billion by 2021 according to new research report

Europe migraine drug market is expected to reach USD 1.33 billion by 2021 according to new research report

Europe Migraine Drug Market By Treatment (Preventive And Absorptive) By Therapeutic Class (triptants, Ergots And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

- Advertising -

Europe Migraine Drug Market was worth USD 1.07 billion in 2016 and estimated to be growing at a CAGR of 4.44 %, to reach USD 1.33 billion by 2021. Migraines are a source of both lost productivity and medical costs.

Browse Market data tables and in-depth TOC of the Europe Migraine Drug Market to 2021 at www.marketdataforecast.com/market-…drug-market-4107/

The growing requirement for new treatment choices has prompted to the improvement of new devices, for example, antimigraine devices and headbands in the market. For example, Cefaly Transcutaneous Electrical Nerve Stimulation devices is a FDA affirmed devices for headache treatment.

- Advertising -

This device animates the trigeminal nerve by emanating electric streams and gives reduction from headache. Expanding spending in new research exercises and novel item advancements are relied upon to quicken the development and improvement of this market throughout the following four years.

Market can be segmented by Treatment and Therapeutic class. Treatment can be further segmented into Preventive and Absorptive.

Therapeutic class can be further segmented into triptants, ergots and others.

Report: www.marketdataforecast.com/market-…07/request-sample

Key players in the market are  Allergan, GlaxoSmithKline, Pfizer, Endo, Impax Laboratories.The other prominent vendors the market include AbbottAeriel BioPharma, Alder Biopharmaceuticals, Amgen, Astellas, Bayer, CoLucid, Eli Lilly, IntelGenx, Ethypharm,Johnson & Johnson, Kowa Pharmaceuticals America, Klaria, Luitpold Pharmaceuticals, AstraZeneca, Meda, Dr. Reddy's Laboratories,  OptiNose, Pfizer, Pozen, Eisai, Raptor, RedHill, SUDA, Teva, , Aegis Therapeutics, Merck, TG Therapeutics, NValeant, Winston Pharmaceuticals, Allergan,  and Zogenix.

Report: www.marketdataforecast.com/market-…rket-4107/inquire

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...